Valuation: Bayer AG

Market Cap 55.76B 61.66B 51.47B 46.59B 87.92B 5,797B 90.55B 618B 246B 3,099B 231B 226B 9,864B P/E 2026 *
26.1x
P/E 2027 * 18.9x
Enterprise Value 85.54B 94.59B 78.96B 71.47B 135B 8,892B 139B 948B 377B 4,754B 355B 347B 15,131B EV / Sales 2026 *
1.86x
EV / Sales 2027 * 1.75x
Free-Float
100%
Yield 2026 *
0.24%
Yield 2027 * 0.93%
1 day-0.35%
1 week+0.60%
Current month+11.82%
1 month+29.04%
3 months+17.83%
6 months+47.14%
Current year+52.82%
1 week 53.84
Extreme 53.84
57.84
1 month 43.08
Extreme 43.08
57.84
Current year 32.96
Extreme 32.96
57.84
1 year 26.64
Extreme 26.64
57.84
3 years 18.38
Extreme 18.378
57.84
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 69 28/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
18/03/26 Buy

Director

1,900 0.0002%
18/03/26 Buy

Executive/Senior Manager

13,000 0.0013%
18/03/26 Buy

Director

1,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.35%+0.60%+94.63%+40.52% 61.87B
+0.02%+5.10%+40.92%+134.09% 1,280B
+1.70%+4.47%+46.36%+92.71% 675B
+0.27%+2.49%+26.66%+113.07% 521B
+1.14%+3.78%+39.98%+70.26% 386B
+0.39%+0.62%+61.67%+44.28% 363B
+1.11%+0.07%+28.19%+58.61% 301B
+0.24%-0.80%+3.05%+35.93% 286B
+0.09%+1.72%+39.22%+75.55% 253B
-0.24%+0.82%+36.90%+125.46% 211B
Average +0.42%+0.00%+41.76%+79.05% 434B
Weighted average by Cap. +0.50%+0.27%+38.79%+95.05%

Financials

2026 *2027 *
Net sales 45.97B 50.84B 42.43B 38.41B 72.48B 4,779B 74.65B 509B 202B 2,555B 191B 187B 8,132B 47.2B 52.2B 43.57B 39.44B 74.42B 4,907B 76.65B 523B 208B 2,623B 196B 192B 8,350B
Net income 2.12B 2.34B 1.95B 1.77B 3.33B 220B 3.43B 23.43B 9.31B 118B 8.78B 8.59B 374B 2.87B 3.18B 2.65B 2.4B 4.53B 299B 4.67B 31.85B 12.66B 160B 11.93B 11.68B 509B
Net Debt 29.78B 32.93B 27.48B 24.88B 46.94B 3,095B 48.35B 330B 131B 1,655B 124B 121B 5,267B 26.66B 29.48B 24.61B 22.28B 42.04B 2,772B 43.3B 295B 117B 1,482B 111B 108B 4,717B
Projected Income Statement - Annual - Bayer AG
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,775
Date Price Change Volume
12/11/26 €56.56 -0.35% 2,571,570
11/11/26 €56.76 -0.56% 1,798,543
10/11/26 €57.08 +0.81% 2,629,130
09/11/26 €56.62 +1.87% 2,613,975
06/11/26 €55.58 -1.14% 4,309,484
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Bayer AG
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
56.76EUR
Average target price
60.11EUR
Spread / Average Target
+5.90%
  1. Stock Market
  2. Stocks
  3. BAYN Stock